Brookfield Asset Management - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 129 filers reported holding KEROS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$432,8529,0140.00%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 321,300$12,087,0004.99%
First Light Asset Management, LLC 598,213$22,505,0002.28%
Nantahala Capital Management 845,692$31,815,0002.06%
CHI Advisors LLC 200,229$7,533,0002.03%
Fairmount Funds Management LLC 272,498$10,251,0001.80%
Altium Capital Management LP 88,000$3,311,0001.21%
Orbimed Advisors 1,679,417$63,180,0001.17%
SPHERA FUNDS MANAGEMENT LTD. 206,819$7,781,0001.08%
Parkman Healthcare Partners LLC 99,927$3,759,0001.07%
Soleus Capital Management, L.P. 146,000$5,493,0000.75%
View complete list of KEROS THERAPEUTICS INC shareholders